Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Drug Discovery: Overview

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Giant cell arteritis can occur in people of colour.

The Lancet. Rheumatology·2024

Same author

Should race be considered in diagnosing giant cell arteritis? - Authors' reply.

The Lancet. Rheumatology·2024

Same author

Cannonball opacities in a pregnant woman.

The Lancet. Rheumatology·2024

Same author

Antibody response to mycobacterial Rpf B protein and its immunodominant peptides in HIV-TB co-infected individuals.

Tuberculosis (Edinburgh, Scotland)·2023

Same author

Cutaneous manifestations of VEXAS syndrome: multiple changing faces in the same patient.

International journal of dermatology·2023

Same author

Discovery of triazole tethered thymol/carvacrol-coumarin hybrids as new class of α-glucosidase inhibitors with potent in vivo antihyperglycemic activities.

European journal of medicinal chemistry·2023

Same journal

Identification of MTFR1 as a Novel Prognostic Biomarker and Putative Oncogene for Breast Cancer: A Multi-Omics Analysis and in Vitro Experimental Validation.

IET systems biology·2026

Same journal

scGMB: A scRNA-seq Cell Classification Method Combining GCN and Mamba.

IET systems biology·2026

Same journal

Identification of Chemokine-Related Genes Derived From T and NK Cells in the Tumour Microenvironment of Ovarian Cancer Based on scRNA-Seq.

IET systems biology·2026

Same journal

Unravelling the Mechanism of Compound Kushen Injection in Treating Cervical Cancer Through Ferroptosis Regulation: An Integrated Network Pharmacology and Molecular Docking Study.

IET systems biology·2026

Same journal

Metabolic Reprogramming in Recurrent Spontaneous Abortion: Key Biomarkers Identification and Diagnostic Model Development.

IET systems biology·2026

Same journal

Network Pharmacology and Experimental Validation to Explore the Potential Mechanism of Salvianolic Acid B in Reversing Oxaliplatin Resistance of Colorectal Cancer Cells.

IET systems biology·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Dec 31, 2025

Constructing and Visualizing Models using Mime-based Machine-learning Framework

Constructing and Visualizing Models using Mime-based Machine-learning Framework

Published on: July 22, 2025

Ensembled machine learning framework for drug sensitivity prediction.

Aman Sharma¹, Rinkle Rani²

¹CSED, T.I.E.T, Punjab, Patiala, India. amans.3008@gmail.com.

IET Systems Biology

|January 14, 2020

Summary

This summary is machine-generated.

This study introduces an improved ensemble learning framework for predicting anti-cancer drug responses. The novel approach enhances drug sensitivity prediction accuracy, outperforming existing methods.

More Related Videos

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation

Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation

Published on: February 10, 2023

Related Experiment Videos

Last Updated: Dec 31, 2025

Constructing and Visualizing Models using Mime-based Machine-learning Framework

Constructing and Visualizing Models using Mime-based Machine-learning Framework

Published on: July 22, 2025

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation

Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation

Published on: February 10, 2023

Area of Science:

Computational biology
Pharmacogenomics
Machine learning in oncology

Background:

Drug sensitivity prediction is crucial for drug design and discovery.
Cancer patient responses to therapy are highly heterogeneous.
Existing computational methods for drug sensitivity prediction lack sufficient efficiency.

Purpose of the Study:

To develop an advanced ensemble learning framework for accurate drug-response prediction.
To evaluate the proposed framework against state-of-the-art algorithms and baseline methods.
To assess the framework's potential in predicting missing drug response values.

Main Methods:

An ensemble learning framework utilizing a modified rotation forest was developed.
The framework was tested using drug sensitivity data from Genomics of Drug Sensitivity in Cancer (GDSC) and Cancer Cell Line Encyclopedia (CCLE).
Performance was compared against three state-of-the-art algorithms and two baseline methods.

Main Results:

The proposed framework demonstrated superior performance compared to other methods.
An average mean square error of 3.14 (GDSC) and 0.404 (CCLE) was achieved.
The approach successfully predicted missing drug response values without using gene mutation data.

Conclusions:

The developed ensemble learning framework shows significant potential for improving anti-cancer drug response prediction.
This method offers a promising computational tool for precision oncology.
Further research could explore incorporating gene mutation data to enhance predictive accuracy.